Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMC Cancer|March 16, 2020
Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case reportAndrew D Simmons, Minh Nguyen, Elias Pintus
Clinical Nuclear Medicine|April 10, 2025
Epicardial Metastases Causing Coronary Artery Compression and Myocardial Infarction on [18F]FDG PET-CTJoshua Wilcox, Ankur Gulati, Elias Pintus, et al.
British Dental Journal|February 11, 2022
The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 3: prostate cancerVinod Patel, Megan Burns, Sheelen Patel, et al.
BMC Urology|April 30, 2022
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19Alfred Chung Pui So, Christina Karampera, Muhammad Khan, et al.
European Urology|October 10, 2019
Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS StudyAntoine Thiery-Vuillemin, Mads Hvid Poulsen, Edouard Lagneau, et al.
ESMO Open|August 18, 2018
Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS studyAntoine Thiery-Vuillemin, Mads Hvid Poulsen, Edouard Lagneau, et al.
BJU International|July 1, 2025
Artificial intelligence-driven streamlining of prostate cancer multidisciplinary team recommendations in a tertiary NHS centre in the UKAhmed Khattak, Danny Ruta, Vivek Patkar, et al.
Frontiers in Oncology|January 24, 2024
A cohort profile of the Graham Roberts study cohortBeth Russell, Poppy Leech, Harriet Wylie, et al.
Nature Reviews. Urology|October 18, 2024
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwardsEdward Christopher Dee, Rebecca Todd, Kenrick Ng, et al.
Cancers|December 23, 2022
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World StudyDaniel Johnathan Hughes, Matthaios Kapiris, Andreja Podvez Nevajda, et al.
Pageof 2